Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis [version 2; peer review: 3 approved]

by Gilles Wandeler, Marta Buzzi, Nanina Anderegg, Delphine Sculier, Charles Béguelin, Matthias Egger, Alexandra Calmy
Published 2019-04-01

Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis [version 1; referees: 3 approved]

by Gilles Wandeler, Marta Buzzi, Nanina Anderegg, Delphine Sculier, Charles Béguelin, Matthias Egger, Alexandra Calmy
Published 2018-08-01

Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review.

by Catrina Mugglin, Gilles Wandeler, Janne Estill, Matthias Egger, Nicole Bender, Mary-Ann Davies, Olivia Keiser
Published 2013-01-01

HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modelling

by Reneé de Waal, Richard Lessells, Anthony Hauser, Roger Kouyos, Mary-Ann Davies, Matthias Egger, Gilles Wandeler
Published 2018-11-01

Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta‐Analysis

by Nathan Ford, Roz Scourse, Maud Lemoine, Yvan Hutin, Marc Bulterys, Zara Shubber, Dmytro Donchuk, Gilles Wandeler
Published 2018-10-01

Modelling the impact of different testing strategies for HCV infection in Switzerland

by Maryam Sadeghimehr, Barbara Bertisch, Christian Schaetti, Gilles Wandeler, Jean-Luc Richard, Claude Scheidegger, Olivia Keiser, Janne Estill
Published 2019-10-01

Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa.

by Anthony Hauser, Katharina Kusejko, Leigh F Johnson, Gilles Wandeler, Julien Riou, Fardo Goldstein, Matthias Egger, Roger D Kouyos
Published 2019-06-01

Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study.

by Anthony Hauser, Katharina Kusejko, Leigh F Johnson, Huldrych F Günthard, Julien Riou, Gilles Wandeler, Matthias Egger, Roger D Kouyos
Published 2020-12-01

Hepatosplenic schistosomiasis in Zambian adults is characterized by increased liver stiffness: A nested case-control study

by Edford Sinkala, Michael Vinikoor, Alice Miyanda Siyunda, Kanekwa Zyambo, Ellen Besa, Bright Nsokolo, Gilles Wandeler, Graham R. Foster, Paul Kelly
Published 2020-07-01

Awareness and management of elevated blood pressure among human immunodeficiency virus–infected adults receiving antiretroviral therapy in urban Zambia: a call to action

by Sophie Bauer, Mwanza Wa Mwanza, Roma Chilengi, Charles B. Holmes, Zude Zyambo, Hansjakob Furrer, Matthias Egger, Gilles Wandeler, Michael J. Vinikoor
Published 2017-01-01

A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA.

by Gilles Wandeler, Olivia Keiser, Bernard Hirschel, Huldrych F Günthard, Enos Bernasconi, Manuel Battegay, Olivier Clerc, Pietro L Vernazza, Hansjakob Furrer, Swiss HIV Cohort Study
Published 2011-01-01

Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa

by Patrick A. Coffie, Boris K. Tchounga, Guillaume Bado, Mathieu Kabran, Daouda K. Minta, Gilles Wandeler, Geoffrey S. Gottlieb, François Dabis, Serge P. Eholie, Didier K. Ekouevi
Published 2017-07-01

Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort

by Bernard Surial, Matthias Cavassini, Alexandra Calmy, Jan Fehr, Marcel Stöckle, Enos Bernasconi, Bianca Roth, Christoph A. Fux, Helen Kovari, Hansjakob Furrer, Andri Rauch, Gilles Wandeler, the Swiss HIV Cohort Study
Published 2019-10-01

Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared

by Gilles Wandeler, Lloyd Mulenga, Michael J. Vinikoor, Helen Kovari, Manuel Battegay, Alexandra Calmy, Matthias Cavassini, Enos Bernasconi, Patrick Schmid, Carolyn Bolton-Moore, Edford Sinkala, Benjamin H. Chi, Matthias Egger, Andri Rauch
Published 2016-10-01

The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study

by Bernard Surial, Nicolas Bertholet, Jean-Bernard Daeppen, Katharine E. A. Darling, Alexandra Calmy, Huldrych F. Günthard, Marcel Stöckle, Enos Bernasconi, Patrick Schmid, Andri Rauch, Hansjakob Furrer, Gilles Wandeler, the Swiss HIV Cohort Study
Published 2021-01-01

Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study.

by Janne Estill, Matthias Egger, Leigh F Johnson, Thomas Gsponer, Gilles Wandeler, Mary-Ann Davies, Andrew Boulle, Robin Wood, Daniela Garone, Jeffrey S A Stringer, Timothy B Hallett, Olivia Keiser, IeDEA Southern Africa Collaboration
Published 2013-01-01

Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.

by Tracy R Glass, Margalida Rotger, Amalio Telenti, Laurent Decosterd, Chantal Csajka, Heiner C Bucher, Huldrych F Günthard, Martin Rickenbach, Dunja Nicca, Bernard Hirschel, Enos Bernasconi, Gilles Wandeler, Manuel Battegay, Catia Marzolini, Swiss HIV Cohort Study
Published 2012-01-01

Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.

by Gilles Wandeler, Kalo Musukuma, Samuel Zürcher, Michael J Vinikoor, Jara Llenas-García, Mussa M Aly, Lloyd Mulenga, Benjamin H Chi, Jochen Ehmer, Michael A Hobbins, Carolyn Bolton-Moore, Christopher J Hoffmann, Matthias Egger, IeDEA-Southern Africa
Published 2016-01-01

Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa

by Patrick A. Coffie, Matthias Egger, Michael J. Vinikoor, Marcel Zannou, Lameck Diero, Akouda Patassi, Mark H. Kuniholm, Moussa Seydi, Guillaume Bado, Ponsiano Ocama, Monique I. Andersson, Eugène Messou, Albert Minga, Philippa Easterbrook, Kathryn Anastos, François Dabis, Gilles Wandeler, for the IeDEA collaboration
Published 2017-11-01

Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority S...

by Delphine Sculier, Gilles Wandeler, Sabine Yerly, Annalisa Marinosci, Marcel Stoeckle, Enos Bernasconi, Dominique L Braun, Pietro Vernazza, Matthias Cavassini, Marta Buzzi, Karin J Metzner, Laurent A Decosterd, Huldrych F Günthard, Patrick Schmid, Andreas Limacher, Matthias Egger, Alexandra Calmy, Swiss HIV Cohort Study (SHCS)
Published 2020-11-01